Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Food and Drug Administration, Eli Lilly
Eli Lilly’s weight-loss drug no longer in shortage, FDA says
The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug Administration announced Wednesday.
Eli Lilly’s Weight-Loss Drugs Are No Longer in Short Supply. Bad News for Hims & Hers.
Blockbuster drugs Zepbound and Mounjaro have come off the FDA's shortage list. Shares of Hims & Hers, which had capitalized on the pinch, are tumbling.
Mounjaro, Zepbound shortage eases as supplies of weight loss drug rebound
Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit cheaper copycat versions.
1d
on MSN
Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says
The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making ...
Daily Reporter
2d
Eli Lilly’s weight-loss drugs no longer in shortage, FDA says
Indianapolis-based Eli Lilly’s supply of Mounjaro, which is used to treat Type 2 diabetes, and popular weight-loss drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
US adds 254,000 jobs
Ex-Lions quarterback dies
Registration deadlines
US launches airstrikes
Warns of potential threats
Tucker faces defamation suit
Yellow jackets swarm in NC
Glover cancels tour dates
Bans pagers, walkie-talkies
Mich. double voting incident
Sixth Player of the Year
Hurricane forecast for FL
To resume talks with union
Paterson, stepson attacked
Bills Hall of Famer dies
Trump returns to Butler
Judge denies request
To stop linking to NZ news?
To lead LA police force
US, SK troop-funding deal
US $157M aid for Lebanon
Won’t renew CHNV parole
Stellantis sues UAW
SCOTUS allows EPA rules
To weigh TX death row case
Bird flu vaccine supply boost
ULA launches Vulcan rocket
Catches fire while landing
Read seeks to delay lawsuit
To add Hyundai EVs
Reaches China Open final
Feedback